This company is no longer active
Second Sight Medical Products Management
Management criteria checks 3/4
Key information
Scott Dunbar
Chief executive officer
US$301.4k
Total compensation
CEO salary percentage | 77.8% |
CEO tenure | 1.4yrs |
CEO ownership | 0.006% |
Management average tenure | no data |
Board average tenure | 7.1yrs |
Recent management updates
Recent updates
Second Sight, Nano Precision complete merger, renaming as Vivani Medical
Aug 30Second Sight Medical sheds ~17% after reverse stock split
Aug 19Second Sight stock rises as shareholders approve merger, name change, reverse stock split
Jul 29Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial
Jul 18Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing
Mar 22Second Sight Medical rises defying legal battle; regains NASDAQ compliance
Jun 04CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -US$9m |
Mar 31 2022 | n/a | n/a | -US$8m |
Dec 31 2021 | US$301k | US$235k | -US$9m |
Sep 30 2021 | n/a | n/a | -US$9m |
Jun 30 2021 | n/a | n/a | -US$8m |
Mar 31 2021 | n/a | n/a | -US$9m |
Dec 31 2020 | US$342k | US$255k | -US$15m |
Compensation vs Market: Scott's total compensation ($USD301.39K) is below average for companies of similar size in the US market ($USD764.69K).
Compensation vs Earnings: Scott's compensation has been consistent with company performance over the past year.
CEO
Scott Dunbar (64 yo)
1.4yrs
Tenure
US$301,389
Compensation
Mr. Scott Dunbar has been Acting Chief Executive Officer at Second Sight Medical Products, Inc since March 26, 2021. For many years he served Second Sight as Patent Counsel, Senior Patent Counsel, and Seni...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 7.3yrs | US$55.00k | 0.038% $ 20.4k | |
Independent Director | 24.6yrs | US$59.00k | 0% $ 0 | |
Independent Non-Executive Chairman | 13.2yrs | US$54.00k | 19.28% $ 10.5m | |
Director | 7yrs | US$35.00k | 0.052% $ 28.2k | |
Independent Director | 1.3yrs | US$59.00k | no data | |
Independent Director | 1.3yrs | US$35.00k | 0.0013% $ 690.7 |
7.1yrs
Average Tenure
63.5yo
Average Age
Experienced Board: EYES's board of directors are considered experienced (7.1 years average tenure).